MONARSEN

Designated

Approval Year

Substance Class	Nucleic Acid
Nucleic Acid Type	OLIGONUCLEOTIDE
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	4TT3V55XYT
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

EN-101

Preferred Name

English

MONARSEN

Common Name

English

BL-7040

Code

English

0DN-7040

Common Name

English

DNA, D(C-T-G-C-G-A-T-A-T-T-T-T-C-T-T-G-T-RAM-RCM-RCM)

Common Name

English

Showing 1 to 5 of 5 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

Designated/Withdrawn

FDA ORPHAN DRUG

173903

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

CAS

864021-55-6

PRIMARY

FDA UNII

4TT3V55XYT

PRIMARY

SMS_ID

300000022451

PRIMARY

Showing 1 to 3 of 3 entries

Previous1Next

Subunit 0

Show entries

Sugar	Site Range	Site Count
2'-O-Methyl-Ribose	1_18-1_20	3 / 20
Deoxyribose (DNA)	1_1-1_17	17 / 20

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Linkage	Site Range	Site Count
Phosphate	1_2-1_20	19 / 19

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Related Record

Type

Details


					EK71H4HC3N

ACETYLCHOLINESTERASE HUMAN

TARGET->INHIBITOR OF EXPRESSION

Amount:


					23MZ977QUX

MONARSEN SODIUM

SALT/SOLVATE -> PARENT

Amount:

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Related Record

Type

Details


					4TT3V55XYT

MONARSEN

ACTIVE MOIETY

Comments:

Monarsen was shown to improve the Quantitativ emyasthenia gravis (QMG) score in 14 of the 16 patients examined,

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL

Showing 1 to 1 of 1 entries

Previous1Next